RenovoRx Inc (NAS:RNXT)

Q1 2026 RenovoRx Inc Earnings Call Transcript

May 14, 2026 / 08:30 PM GMT

Release Date Price: $0.855 (+0.75%)

Transcript 10-K/A10-Q8-K

Key Points

Positve

RenovoRx Inc (RNXT) reported its highest quarterly revenue to date in Q1 2026, with $563,000, marking a 136% growth compared to Q4 2025.
The company expanded its active commercial cancer centers from 8 at the end of 2025 to 16 by May 2026, indicating strong commercial momentum.
RenovoRx Inc (RNXT) was recognized by Fast Company as one of the world's most innovative companies of 2026 in the medical devices category.
The company successfully closed an oversubscribed private placement, generating approximately $10 million in gross proceeds, reflecting strong investor confidence.
RenovoRx Inc (RNXT) maintains a robust pipeline with 32 additional centers in various stages of evaluation, approval, or activation, supporting future growth.

Negative

Research and development expenses for Q1 2026 were $1.2 million, indicating continued high investment costs.
Selling, general, and administrative expenses were approximately $2.7 million, slightly above projections, reflecting potential cost management challenges.
The company is still in the process of completing its Phase III TIGER-PACT trial, with final data not expected until mid to late 2027.
Despite revenue growth, RenovoRx Inc (RNXT) is not yet cash flow positive and relies on its cash reserves to fund operations through the second half of 2027.
The transition of clinical trial sites to commercial centers is ongoing, and the predictability of their revenue contribution remains uncertain.

Refinitiv StreetEvents Event Transcript
E D I T E D V E R S I O N

RNXT.OQ - RenovoRx Inc
Q1 2026 RenovoRx Inc Earnings Call
May 14, 2026 / 08:30PM GMT

=====================
Presentation
--------------------------------------------------------------------------------
Unidentified_1 [1]
--------------------------------------------------------------------------------
Good afternoon.

I will be your conference call operator today.

Please note that today's call is being recorded and all participants other than management are in a listen-only mode.

There will be a Q&A session following management's presentation.

I will now turn the call over to Walter Pinto, Managing Director of KCSA Strategic Communications. Please go ahead.

--------------------------------------------------------------------------------
Unidentified_2 [2]
--------------------------------------------------------------------------------
Thank you, operator. Good afternoon, everyone, and welcome to the RenovaRx first quarter 2026 earnings conference call. I'm joined today by members of

Already have an account? Log in

Get the full story

Subscribe Now

	Access to All Earning Calls and Stock Analysis
	30-Year Financial on one screen
	All-in-one Stock Screener with unlimited filters
	Customizable Stock Dashboard
	Real Time Insider Trading Transactions
	8,000+ Institutional investors’ 13F holdings
	Powerful Excel Add-in and Google sheets Add-on
	All data downloadable
	Quick customer support
	And much more...

30-Day 100% money back guarantee

Subscription fee may be tax deductible.

Excellent

4.6 out of 5

Trustpilot

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Calculators Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App Newsletters Signup 中文

Education

Financial Glossary Tutorials FAQ Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.